Electronic pill bottles to monitor and promote medication adherence for people with multiple sclerosis: A randomized, virtual clinical trial
| Autor: | Andrew Siyoon Ham, Spencer K. Hutto, Rebecca L. Gillani, Andre C. Vogel, Marcelo Matiello, Tamara B. Kaplan, Kristin M. Galetta, Gladia C. Hotan, Farrah J. Mateen, Ilena C. George, Dylan R. Rice, Eric C. Klawiter |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
medicine.medical_specialty Multiple Sclerosis Dimethyl Fumarate Medication Adherence law.invention chemistry.chemical_compound Randomized controlled trial law Teriflunomide medicine Humans Medical prescription mHealth Fingolimod Hydrochloride business.industry Multiple sclerosis Middle Aged medicine.disease Fingolimod Clinical trial Neurology chemistry Pill Physical therapy Female Neurology (clinical) Electronics business medicine.drug |
| Zdroj: | Journal of the Neurological Sciences. 428:117612 |
| ISSN: | 0022-510X |
| Popis: | We perform a randomized trial to test the impact of electronic pill bottles with audiovisual reminders on oral disease modifying therapy (DMT) adherence in people with MS (PwMS).Adults with multiple sclerosis (MS) taking an oral DMT were randomized 1:1 for 90 days to remote smartphone app- and pill bottle-based (a) adherence monitoring, or (b) adherence monitoring with audiovisual medication reminders. Optimal adherence was defined as the proportion of doses taken ±3 h of the scheduled time. Numbers of missed pills and pills taken early, on time, late, and extra were recorded. A multivariable regression model tested possible associations between optimal adherence and age, MS duration, cognitive functioning, and number of daily prescription pills.85 participants (66 female; mean age 44.9 years) took dimethyl/diroximel fumarate (n = 49), fingolimod (n = 26), or teriflunomide (n = 10). Optimal adherence was on average higher in the monitoring with reminders arm (71.4%) than the monitoring only arm (61.6%; p = 0.033). In a multivariable model, optimal adherence was less likely in younger participants (p 0.001) and those taking more daily prescription pills (p 0.001). In the monitoring only arm, 4.0% of doses were taken early, 61.6% on time, 5.6% late, 4.4% in excess, and 24.4% were missed. In the reminders arm, these proportions were 3.4%, 71.4%, 3.7%, 8.7%, and 12.8%, respectively.We map real-world oral DMT adherence patterns using mHealth technology. PwMS who received medication reminders had higher optimal adherence. Nonadherence was more nuanced than simply missing pills. Developing strategies to improve adherence remains important in longitudinal MS care. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect